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Abstract A novel peptide, PNP (Pseudocerastes persicus
natriuretic peptide), was isolated from the venom of the Iranian
viper P. persicus. Amino acid sequencing revealed that the
37-residue peptide belongs to the family of natriuretic peptides.
The physiological e¡ects of intra-venously PNP infused into
anesthetized rats on urine £ow, sodium excretion and blood
pressure were comparable to those of atrial natriuretic peptide
(ANP). In PC12 cells that were treated with either PNP, ANP,
or C-type natriuretic peptide, PNP induced a similar cGMP
response as ANP. Since PC12 cells only express the natriuretic
peptide receptor (NPR)-A receptor we conclude that PNP binds
to the NPR-A receptor. The solution conformation of PNP
was characterized using 1H nuclear magnetic resonance spec-
troscopy and indicates a high degree of conformational £exi-
bility.
/ 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
The natriuretic peptide family includes many structurally
related peptides that are involved in physiological processes
controlling natriuresis, diuresis, blood pressure, homeostasis,
and inhibition of aldosterone secretion (for review see [1^3]).
Natriuretic peptides are characterized by a homologous se-
quence of 17 amino acids that form a ring closed by a cysteine
disul¢de bridge. atrial natriuretic peptide (ANP), the ¢rst fac-
tor identi¢ed, is primarily synthesized in the heart [4] whereas
brain natriuretic peptide (BNP), which was originally isolated
from porcine brain, was later found in heart as well [5]. C-type
natriuretic peptide (CNP), a natriuretic peptide that lacks the
C-terminal extension [6] is expressed predominantly in the
central nervous system and vascular endothelial cells and is
a more potent vasoactive agent than ANP and BNP while its
natriuretic activity is weaker [7].
Natriuretic peptides mediate their function through bind-
ing to high a⁄nity receptors that are found at high concen-
trations in the target organs [6,8]. These receptors belong
to the family of membrane-bound guanylate cyclase receptors
that catalyze the production of the second messenger cyclic
GMP upon stimulation. Three types of receptors of natriu-
retic peptides have been identi¢ed, natriuretic peptide receptor
A, B, and C (NPR-A, NPR-B, and NPR-C). NPR-A is
activated by ANP, but it also binds BNP, albeit with a lower
a⁄nity. NPR-B is preferentially activated by CNP, while
NPR-C, that has only a small intra-cellular segment and
lacks guanylate cyclase activity, binds all three types of
peptides ith equal a⁄nity. It primarily controls the local
concentration of natriuretic peptides available to NPR-A
and NPR-B by internalizing them as a clearance receptor
[9].
Natriuretic peptides have also been isolated from a range of
other vertebrates. Notably, some were found in snake ven-
oms: Dendroaspis auguticeps natriuretic peptide was detected
in the venom of Dendroaspis auguticeps (the green mamba)
and has properties similar to both ANP and CNP [10].
CNP analogs were also cloned from the venom glands of
snakes of the Crotalinae subfamily [11]. Here we present a
functional study of a novel member of the natriuretic peptide
family, Pseudocerastes persicus natriuretic peptide (PNP), iso-
lated from the venom of the Iranian snake Pseudocerastes
persicus.
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2. Materials and methods
2.1. Puri¢cation
P. persicus snakes were milked and the pooled venom was lyophi-
lized and stored at 320‡C. The dried crude venom (1 g) was dissolved
into 25 ml of mobile phase (0.05 M ammonium acetate, pH 6.8) and
was applied on a Sephadex G-50 column (210U3.5 cm; £ow rate: 60
ml/h; fraction: 5 ml) (Pharmacia, Uppsala, Sweden). Lyophilized
fractions were further puri¢ed by a semi-preparative reversed phase
(RP)-HPLC C8 column (250U10 mm, 5 Wm) (Merck (Darmstadt,
Germany) or Vydac (Hesperia, CA, USA)) equilibrated in 0.1% w/v
tri£uoroacetic acid. Elution was performed using a linear gradient
(10^30%) of acetonitrile containing 0.1% w/v tri£uoroacetic acid in
40 min (2 ml/min) and absorbance measured at 215 nm. The fraction
corresponding to PNP was lyophilized and further analyzed by an
analytical RP-HPLC C8 column (250U4.6 mm, 5 Wm).
2.2. Reduction and alkylation
PNP (1.8 nmol) was reduced for 1 h at 37‡C (N2 atmosphere) with
a 10-fold excess of dithiothreitol (with respect to disul¢de) in 100 mM
Tris^HCl bu¡er, pH 8.0, containing 6 M guanidium^HCl. The gen-
erated thiol groups were alkylated in dark with a ¢ve-fold excess of
iodoacetamide.
2.3. Enzymatic cleavage
PNP (3 nmol) was cleaved with trypsin (Promega, Madison, WI,
USA) at an enzyme/substrate ratio of 1:50 (w/w) for 18 h at room
temperature in 100 mM Tris^HCl bu¡er, pH 8.0, in the presence of 20
mM iodoacetamide to prevent disul¢de exchange. Reduced and alky-
lated PNP (500 pmol) was cleaved with endoproteinase Asp-N
(Boehringer Mannheim, Germany) at an enzyme/substrate ratio of
1:50 (w/w) for 18 h at 37‡C in 50 mM Tris^HCl bu¡er, pH 8.0.
2.4. RP-HPLC
The peptide mixtures were separated by RP-HPLC on an Aquapore
Butyl column (2.1U100 mm, wide-pore, 30 nm, 7 Wm; Applied Bio-
systems) with a Hewlett Packard 1090 liquid chromatograph (Hewlett
Packard) using acetonitrile gradients.
2.5. Amino acid analysis
Samples were hydrolyzed in the gas phase with 6 M hydrochloric
acid containing 0.1% (by volume) phenol for 24 h at 115‡C under N2
vacuum [12]. The liberated amino acids were reacted with phenyliso-
thiocyanate and the resulting phenylthiocarbamoyl amino acids ana-
lyzed by RP-HPLC on a Nova Pak ODS column (3.9U150 mm, 4 Wm;
Waters) in a Hewlett Packard liquid chromatograph 1090 with an
automatic injection system [13].
2.6. Amino acid sequence analysis
The N-terminal sequence analysis was carried out either in a Procise
cLC 492 protein sequencer or in a pulsed-liquid phase sequencer
477A, both from Applied Biosystems. The released amino acids
were analyzed on-line by RP-HPLC. In the case of the disul¢de-linked
peptide the di-phenylthiohydantoin-cystine was detected as a double
peak in the vicinity of phenylthiohydantoin-Tyr [14,15]).
2.7. Mass spectrometry
Masses of the peptides were determined by electrospray ionization
mass spectrometry with a single-stage quadrupole instrument (VG
Platform, Micromass).
2.8. Sequence comparison
The sequences of the natriuretic peptides were obtained by a Blast
search using the PNP sequence as query. A multiple sequence align-
ment was obtained with ClustalW [16] and manually adjusted.
2.9. Physiological assay
Experiments were performed on Wistar rats (200^250 g) in accor-
dance with local guidelines of animal care. The animals were deprived
of food the night before the experimentation but were allowed free
access to water. After anesthesia with thiobutabarbital (Inactin, 100
mg/kg i.p., Byk Gulden, Konstanz, Germany), they were placed on a
thermostat table to maintain body temperature at 36^37‡C. The tra-
chea was cannulated for free breathing. Cannulas were inserted into
the left femoral vein for infusion of saline (1.5 ml/h), ANP (kindly
provided by Dr. Forssmann, Lower Saxony Institute for Peptide Re-
search, Hannover, Germany), or PNP and into the left femoral artery
for monitoring arterial blood pressure. After opening the abdomen by
a sub-umbilical incision both ureters were cannulated. Urine from
both ureters was collected into pre-weighed Eppendorf tubes to de-
termine diuresis gravimetrically. Sodium excretion was determined by
measuring its concentration in urine (Electrolyte Analyzer, AVL,
Graz, Austria). Experiments commenced after a 1 h stabilization pe-
riod. The experimental protocol consisted of six periods. In the ¢rst
two control periods (C1 and C2) urine samples were collected for 10
min each. Thereafter, ANP or PNP was infused intra-venously for 25
min at a rate of 3U10311 mol/min (3U1036 stock solution, 10 Wl/
min). For the two experimental periods (E1 and E2, 5 min each) urine
was collected 10 and 20 min past the beginning of the infusion. For
the recovery periods (R1 and R2, 10 min each) urine collection was
started at the 10th and 20th min after stopping the infusion.
2.10. Determination of receptor speci¢city
PC12 cells and di¡erentiated conditionally immortalized mouse po-
docytes were each cultured and seeded at con£uent density in multi-
well plates. After 2^3 days, cells were washed with RPMI 1640 me-
dium and incubated for 20 min with agonists (PNP, ANP, CNP) in
RPMI 1640 at various concentrations at 37‡C. Thereafter cells were
lysed. Total cGMP (cell+medium) concentration was measured with a
colorimetric enzyme immuno-assay (Amersham Biosciences) accord-
ing to the manufacturer’s protocol including an acetylation reaction.
Optical densities were read with a microplate reader (Bio-Rad) at 450
nm. CNP was purchased from Bachem.
2.11. Nuclear magnetic resonance (NMR) spectroscopy
The peptide was dissolved in 600 Wl H2O:D2O 9:1 either at pH 4.0
or pH 6.0 to a ¢nal concentration of 1 mM. NMR spectra of PNP in
water, pH 4.0, were acquired at 4‡C on either a Bruker DRU500 or
DRU600 spectrometer equipped with a cryoprobe. Additional spectra
were recorded at 14‡C and 24‡C to resolve signal overlap. Spectra
were also recorded at pH 6.0 to probe the in£uence of pH on the
conformation.
Total correlation spectroscopy (TOCSY) spectra were measured
using the DIPSI-2rc sequence [17]. Water suppression was achieved
by applying WATERGATE [18]. A series of mixing times between 40
and 65 ms was used for the TOCSY spectra. Two-dimensional nuclear
Overhauser e¡ect correlation spectroscopy (NOESY) spectra were ac-
quired with 150 and 300 ms mixing time to identify long range NOEs
and to facilitate sequential assignments. 3JHNHK couplings were de-
rived from COSY spectra [19].
Data were processed using the Bruker XWIN-NMR software (ver-
sion 2.6) and analyzed with XEASY [20].
2.12. Restraints and structure calculation
Structure calculation was performed with a simulated annealing
protocol using CNS (version 1.1) [21] and the standard protocol of
ARIA (version 1.2) [22]. Three di¡erent ensembles each comprising 50
structures were generated, of which the 10 best structures were further
re¢ned in a shell of water [23]. The ¢rst set contained information of
three additional NOEs that were used as ambiguous distance re-
straints. In a second calculation these NOEs were assigned to medium
range distance restraints between His17/Ile19 and His25/Leu28, and in
a third calculation they were assigned to long range distance restraints
between His17/Leu28 and His25/Ile19.
The structures were superimposed onto the backbone heavy atoms
of the lowest energy structure of residues 14^30. The structural mod-
els were visualized with the program MOLMOL [24].
3. Results
3.1. Puri¢cation of PNP
Fig. 1A shows the chromatogram of the crude venom ap-
plied to a Sephadex G-50 gel ¢ltration column. PNP was
eluted in fractions between the third and the fourth peak.
These fractions were applied on a semi-preparative RP-
HPLC C8 column, Fig. 1B. The peak corresponding to
23.15% (26.29 min) acetonitrile contained PNP. To verify its
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purity, this fraction was further analyzed on an analytical RP-
HPLC C8 column, Fig. 1C.
3.2. Protein analysis of PNP
PNP exhibits an experimental molecular mass of
3941.50T 0.17 Da when analyzed by mass spectrometry (cal-
culated value 3942.45 Da). After reduction and alkylation the
mass of PNP increased to a value of 4057.25T 0.23 Da (cal-
culated value 4058.59 Da) indicative of two Cys residues. The
reduced^alkylated peptide was sequenced by Edman degrada-
tion. Comparison of the sequence data with those of the ami-
no acid composition and the molecular mass indicated that
PNP contains two additional residues at the C-terminal end.
Therefore, reduced and alkylated PNP was cleaved with en-
doproteinase Asp-N and the peptide mixture was separated by
RP-HPLC and analyzed by mass spectrometry. Peak 6 con-
tained the C-terminal peptide (Asp20^His37), which was con-
¢rmed by Edman degradation. The entire amino acid se-
quence of PNP (Swiss-Prot # P82972) is GENEPPKKK-
APDGCFGHKIDRIGSHSGLGCNKFKPGH.
Cleavage of the native PNP with trypsin did not a¡ect the
region between the two Cys residues (14 and 30) which form a
disul¢de bridge. Analysis of the fragments by RP-HPLC,
mass spectrometry and sequence analysis yielded the expected
double sequence with the release of di-phenylthiohydantoin-
cystine in position 9.
3.3. Multiple sequence alignment
The family of natriuretic peptides is characterized by a con-
served loop of 17 residues formed by an intra-molecular di-
sul¢de linkage. The N- and C-terminal ends vary considerably
both in length and amino acid composition among the family
(Fig. 2). Based on its primary sequence, PNP cannot be easily
grouped together with either ANP or BNP. Its closest homo-
logs found through a BLAST search were lebetins, peptides
isolated from the venom of Macrovipera lebetina [25].
3.4. Physiological assay
Since PNP is highly homologous to the natriuretic peptides
we tested its in£uence on the renal and blood system. For this
purpose, puri¢ed PNP was infused intra-venously into rats. A
control group was treated with ANP. At period C2 which
served as baseline the values for blood pressure (mm Hg),
diuresis (Wl/min), and Naþ excretion (Wmol/min) were
111T 2, 20.1T 2.8, and 2.4T 0.3 for the group injected with
Fig. 1. Puri¢cation of PNP from the crude venom of P. persicus. A:
Elution chromatogram of the crude venom on a Sephadex G-50 gel
¢ltration column. B: The fractions between the third and the fourth
peak of (A) were applied to a semi-preparative RP-HPLC C8 col-
umn. PNP elutes at 23.15% (26.29 min) of acetonitrile. C: Further
analysis of PNP by analytical RP-HPLC C8 column.
Fig. 2. Multiple sequence alignment of natriuretic peptides. Con-
served residues are printed in bold letters and highlighted. The di-
sul¢de bridge that is characteristic for these peptides is bridged. h, p
and m are human, porcine and murine peptides.
Fig. 3. E¡ects of PNP after intra-venous injection into rats. A:
Urine £ow, B: urinary sodium excretion, C: systemic blood pres-
sure. Open circles, PNP; closed circles, ANP. C1 and C2 are con-
trol periods, E1 and E2 are experimental periods during infusion of
the peptides and R1 and R2 are the recovery periods after stopping
the infusion.
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ANP (n=6) and 110T 4, 12.7 T 3.1 and 2.3 T 0.7 for the group
injected with PNP (n=7), respectively. Fig. 3A shows the
e¡ect of ANP and PNP on diuresis. Both peptides increase
urine £ow signi¢cantly and to a comparable degree during the
experimental periods E1 and E2. In contrast to the ANP
group, the rise in urine £ow did not recover completely in
the PNP group during the recovery period R1. Equipotent
e¡ects of ANP and PNP on natriures are clearly seen in
Fig. 3B although the natriuretic e¡ect of PNP did not recover
completely in the period R1, either. As shown in Fig. 3C, both
peptides reduced systemic blood pressure by about 10 mm Hg,
and the pressure change recovered during periods R1 and R2.
The slightly prolonged e¡ects of PNP versus ANP may be
related to the slower rate of removal of PNP in vivo, i.e.
removal by neutral endopeptidase and the clearance receptor
(NPR-C).
3.5. Interaction with NPR-A receptor
The results obtained from the physiological experiments in
rats suggested that PNP binds in a similar way to the natriu-
retic peptide receptors as ANP. Thus, we tested its ability to
induce the formation of cGMP in two previously character-
ized cell lines. PC12 cell lines have been reported to express
only the NPR-A receptor [26] which we con¢rmed by RT-
PCR. CNP did not increase the basal cGMP levels, consistent
with the fact that CNP speci¢cally binds the NPR-B receptor
(Fig. 4A). In contrast, the cGMP concentration after treat-
ment of the cells with either ANP or PNP was comparable.
ANP and CNP induce a similar response in podocytes.
These cells express both NPR-A and NPR-B (data not shown)
and were used as control for the speci¢city of the interaction
(Fig. 4B). Surprisingly, the amount of cGMP induced by PNP
was higher than that induced by either ANP or CNP. Mass
spectrometry analysis revealed that the PNP was partially
degraded, such that the C-terminal part beyond residue 32
was lost. Since such a truncated PNP resembles more closely
CNP (which lacks any C-terminal residues beyond the second
cysteine) it is possible that the increased cGMP response in
podocytes resulted from the loss of the C-terminal sequence of
PNP and thus enabled it to bind both the NPR-A and NPR-B
receptors.
3.6. NMR analysis
Using standard methods for sequential assignments based
on homonuclear TOCSY and NOESY spectra, essentially all
of the backbone and side chain protons could be assigned
(Fig. 5). Side chain resonances were una¡ected by temperature
(4 vs. 24‡C) or pH (4 vs. 6) indicating that no major structural
rearrangements occur. The low deviation of the HK chemical
shifts from random coil values together with most values for
the vicinal JHNHK couplings at 6^8 Hz (see supporting infor-
mation) indicates a high degree of conformational averaging.
Nevertheless, we found sequential HN^HN NOEs throughout
the sequence (Fig. 6). Likewise, a few weak NOEs were ob-
served involving the aromatic side chains of the histidines.
Due to signal overlap we could not unambiguously assign
these peaks nor ¢nd others that either support or contradict
them. They could be either assigned to the interactions His17/
Fig. 4. E¡ects of PNP, ANP, and CNP on the formation of cGMP
in (A) PC12 cells, (B) podocytes. The formation of cGMP depend-
ing on the amount of PNP is shown on the left. The EC50 value
represents the e¡ective concentration of PNP that is needed to in-
duce 50% of the maximum e¡ect. The e¡ects of PNP, ANP and
CNP are compared at equal concentrations on the right. SEM, stan-
dard error of the mean; P6 0.05 signi¢cant di¡erence (Student’s t-
test).
Fig. 5. Part of the NOESY ¢ngerprint region of PNP in water, pH
4.0, 4‡C with a mixing time of 150 ms. Sequential connectivities are
indicated.
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Ile19, His25/Leu28 or His17/Leu28, His25/Ile19, residues
within the central 17-membered ring of the peptide (Fig. 6).
To test these assignment possibilities we performed a series of
structure calculations. When the ambiguous NOEs were either
not assigned, or assigned to interactions between neighboring
residues, PNP forms a loose structural bundle without any
de¢ned interactions (‘open’ conformation, Fig. 6). If the am-
biguous restraints were assigned to the long range distance
restraints His17/Leu28 and His25/Ile19 a more compact
‘closed’ structure was formed (Fig. 6). All structural bundles
equally well ¢tted the experimental restraints, re£ecting the
low number of distance restraints.
4. Discussion
Based on the results of the physiological assay in Wistar
rats, the receptor binding assay, and sequence homology we
conclude that the newly isolated peptide PNP is a new mem-
ber of the natriuretic peptide family with features similar to
ANPs.
Our structural analysis is consistent with previous studies
on natriuretic peptides that could only ¢nd signs of local
interactions but no de¢ned secondary structures [27^31]. The
‘closed’ conformation could resemble a transiently sampled
conformation which might facilitate the transition to the re-
ceptor-bound conformation.
The high sequence conservation of the comparably long N-
terminal sequence of PNP with lebetin 2K is intriguing. The
N-terminal sequence in both PNP and lebetin 2K exhibits
several conserved charged residues. ANP, which appears to
be the natriuretic peptide that is closest in function, only
contains two positively charged residues within a six residue
short tail. Notably, initial tests to see whether PNP likewise is
capable to prevent platelet aggregation induced by thrombin
were positive. Thus, lebetin peptides and PNP may be proto-
types of a new class of natriuretic peptides that also exhibit
platelet aggregation properties.
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